Abstract
Infection prevention guidelines do not endorse chlorhexidine gluconate (CHG) use in neonates who are less than 2 months old. A survey of US neonatology program directors revealed that most neonatal intensive care units use CHG, often with some restrictions. Prospective studies are needed to further address concerns regarding the safety of CHG in patients in the neonatal intensive care unit.
Publication types
-
Research Support, N.I.H., Extramural
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Anti-Infective Agents, Local / adverse effects*
-
Anti-Infective Agents, Local / therapeutic use*
-
Chlorhexidine / adverse effects
-
Chlorhexidine / analogs & derivatives*
-
Chlorhexidine / therapeutic use
-
Cross Infection / prevention & control*
-
Health Care Surveys
-
Humans
-
Infant
-
Infant, Newborn
-
Intensive Care Units, Neonatal*
-
United States
Substances
-
Anti-Infective Agents, Local
-
chlorhexidine gluconate
-
Chlorhexidine